In the current study, we build upon the recent findings in B cell lymphomas that mutation of a single BCR CD79 tyrosine appears to block BCR internalization [32], and establish the mechanistic details of antigen-induced AP2-mediated BCR internalization. This evidence concerns the gene BCR and B-cell non-Hodgkin lymphoma.